Mirtazapine in relapse prevention: a double-blind placebo-controlled study in depressed outpatients
β Scribed by M.E. Thase; A.A. Nierenberg; M.B. Keller
- Book ID
- 119574693
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 294 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0924-977X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a controlled double-blind study, sulpiride 10G200mg daily or placebo was administered over a five-month period to 22 and 24 depressive elderly outpatients. The majority of the patinets in both groups were diagnosed as suffering from relatively mild degrees of depression, i.e. from dysthymic disor
## Abstract We sought to determine whether mirtazapine is safe and wellβtolerated as a treatment for essential tremor (ET). We studied mirtazapine in a randomized, doubleβblind, placeboβcontrolled, crossover study of 17 ET patients. Patients were started with 15 mg per day of either mirtazapine or